Product Code: ETC6507400 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brazil Inherited Metabolic Disorders Testing Market Overview |
3.1 Brazil Country Macro Economic Indicators |
3.2 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Brazil Inherited Metabolic Disorders Testing Market - Industry Life Cycle |
3.4 Brazil Inherited Metabolic Disorders Testing Market - Porter's Five Forces |
3.5 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.7 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Brazil Inherited Metabolic Disorders Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about inherited metabolic disorders in Brazil |
4.2.2 Technological advancements in genetic testing and diagnostics |
4.2.3 Growing demand for early and accurate diagnosis of metabolic disorders in infants and children |
4.3 Market Restraints |
4.3.1 High cost associated with genetic testing and diagnostic procedures |
4.3.2 Limited accessibility to specialized healthcare facilities in remote areas of Brazil |
5 Brazil Inherited Metabolic Disorders Testing Market Trends |
6 Brazil Inherited Metabolic Disorders Testing Market, By Types |
6.1 Brazil Inherited Metabolic Disorders Testing Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, By Hurler Syndrome, 2021- 2031F |
6.1.4 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, By Niemann-Pick Disease, 2021- 2031F |
6.1.5 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, By Tay-Sachs Disease, 2021- 2031F |
6.1.6 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, By Gaucher Disease, 2021- 2031F |
6.1.7 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, By Fabry Disease, 2021- 2031F |
6.1.8 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, By Krabbe Disease, 2021- 2031F |
6.2 Brazil Inherited Metabolic Disorders Testing Market, By Therapy Type |
6.2.1 Overview and Analysis |
6.2.2 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, By Enzyme Replacement Therapy, 2021- 2031F |
6.2.3 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, By Cellular Transplantation, 2021- 2031F |
6.2.4 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, By Small Molecule Based Therapy, 2021- 2031F |
6.2.5 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, By Substrate Reduction Therapy, 2021- 2031F |
6.2.6 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.2.7 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, By Drug Therapy, 2021- 2031F |
6.3 Brazil Inherited Metabolic Disorders Testing Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Brazil Inherited Metabolic Disorders Testing Market, By End-user |
6.4.1 Overview and Analysis |
6.4.2 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, By Hospital and Clinics, 2021- 2031F |
6.4.3 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.4.4 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, By Blood Banks, 2021- 2031F |
6.4.5 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.4.6 Brazil Inherited Metabolic Disorders Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Brazil Inherited Metabolic Disorders Testing Market Import-Export Trade Statistics |
7.1 Brazil Inherited Metabolic Disorders Testing Market Export to Major Countries |
7.2 Brazil Inherited Metabolic Disorders Testing Market Imports from Major Countries |
8 Brazil Inherited Metabolic Disorders Testing Market Key Performance Indicators |
8.1 Average turnaround time for test results |
8.2 Number of accredited laboratories offering inherited metabolic disorders testing in Brazil |
8.3 Percentage of newborns screened for metabolic disorders in Brazil |
9 Brazil Inherited Metabolic Disorders Testing Market - Opportunity Assessment |
9.1 Brazil Inherited Metabolic Disorders Testing Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Brazil Inherited Metabolic Disorders Testing Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.3 Brazil Inherited Metabolic Disorders Testing Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Brazil Inherited Metabolic Disorders Testing Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Brazil Inherited Metabolic Disorders Testing Market - Competitive Landscape |
10.1 Brazil Inherited Metabolic Disorders Testing Market Revenue Share, By Companies, 2024 |
10.2 Brazil Inherited Metabolic Disorders Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |